Format

Send to

Choose Destination
Ann Oncol. 2017 May 1;28(5):1158-1159. doi: 10.1093/annonc/mdx067.

Somatic BRCA2 bi-allelic loss in the primary prostate cancer was associated to objective response to PARPi in a sporadic CRPC patient.

Author information

1
Prostate Cancer Unit, Centro Integral Oncológico Clara Campal, Hospital Universitario HM Sanchinarro, Madrid.
2
Prostate Cancer Unit, Spanish National Cancer Research Centre.
3
Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO), Madrid.
4
Pathology Department, Hospital Universitario de Móstoles, Mostoles.
5
START Madrid, Centro Integral Oncológico Clara Campal, Hospital Universitario HM Sanchinarro, Madrid.
6
CNIO-IBIMA Genito-Urinary Cancer Unit, Medical Oncology Department, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga, Spain.
PMID:
28453706
DOI:
10.1093/annonc/mdx067
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center